{
    "nct_id": "NCT05226871",
    "official_title": "A TREATMENT PROTOCOL FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED PALBOCICLIB CLINICAL STUDIES",
    "inclusion_criteria": "* Any participant who is receiving study treatment and deriving clinical benefit as determined by the investigator in a Pfizer-sponsored palbociclib Parent Study\n* Participants must agree to follow the reproductive criteria\n* Participants who are willing and able to comply with all scheduled visits, treatment plans, and other study procedures\n* Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent document and protocol\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Any medical reason that, in the opinion of the investigator or sponsor, precludes the participant from inclusion in the study",
    "miscellaneous_criteria": ""
}